Emergent Biosolutions
EBS
EBS
141 hedge funds and large institutions have $208M invested in Emergent Biosolutions in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11.15% less ownership
Funds ownership: 69.21% → 58.06% (-11%)
47% less call options, than puts
Call options by funds: $3.09M | Put options by funds: $5.83M
Holders
141
Holding in Top 10
1
Calls
$3.09M
Puts
$5.83M
Top Buyers
| 1 | +$4.25M | |
| 2 | +$3.75M | |
| 3 | +$2.8M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.56M |
| 5 |
Jane Street
New York
|
+$2.51M |
Top Sellers
| 1 | -$22M | |
| 2 | -$6.72M | |
| 3 | -$5.86M | |
| 4 |
Renaissance Technologies
New York
|
-$4.89M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$4.83M |